Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
Stone GW; McCullough PA; Tumlin JA; Lepor NE; Madyoon H; Murray P; Wang A; Chu AA; Schaer GL; Stevens M; Wilensky RL; O'Neill WW; JAMA, 2003, vol. 290, issue 17, p 2284, ISSN 15383598. ISBN 15383598.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef